JP2002510689A5 - - Google Patents

Download PDF

Info

Publication number
JP2002510689A5
JP2002510689A5 JP2000542322A JP2000542322A JP2002510689A5 JP 2002510689 A5 JP2002510689 A5 JP 2002510689A5 JP 2000542322 A JP2000542322 A JP 2000542322A JP 2000542322 A JP2000542322 A JP 2000542322A JP 2002510689 A5 JP2002510689 A5 JP 2002510689A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
compound
compound according
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000542322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002510689A (ja
Filing date
Publication date
Priority claimed from US09/054,179 external-priority patent/US5986100A/en
Application filed filed Critical
Publication of JP2002510689A publication Critical patent/JP2002510689A/ja
Publication of JP2002510689A5 publication Critical patent/JP2002510689A5/ja
Pending legal-status Critical Current

Links

JP2000542322A 1998-04-02 1999-02-26 アザトリシクロ化合物 Pending JP2002510689A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/054,179 US5986100A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods for use
US09/054,179 1998-04-02
PCT/US1999/004324 WO1999051601A1 (en) 1998-04-02 1999-02-26 Azatricyclic compounds

Publications (2)

Publication Number Publication Date
JP2002510689A JP2002510689A (ja) 2002-04-09
JP2002510689A5 true JP2002510689A5 (cg-RX-API-DMAC7.html) 2006-01-19

Family

ID=21989278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000542322A Pending JP2002510689A (ja) 1998-04-02 1999-02-26 アザトリシクロ化合物

Country Status (14)

Country Link
US (2) US5986100A (cg-RX-API-DMAC7.html)
EP (1) EP1066287B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002510689A (cg-RX-API-DMAC7.html)
KR (1) KR100613050B1 (cg-RX-API-DMAC7.html)
AT (1) ATE248839T1 (cg-RX-API-DMAC7.html)
AU (1) AU2794899A (cg-RX-API-DMAC7.html)
BR (1) BR9907191A (cg-RX-API-DMAC7.html)
CA (1) CA2317570A1 (cg-RX-API-DMAC7.html)
DE (1) DE69910993T2 (cg-RX-API-DMAC7.html)
DK (1) DK1066287T3 (cg-RX-API-DMAC7.html)
ES (1) ES2205778T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA00009624A (cg-RX-API-DMAC7.html)
PT (1) PT1066287E (cg-RX-API-DMAC7.html)
WO (1) WO1999051601A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010072784A (ko) * 1998-08-18 2001-07-31 지. 카파트 무스카린성 작용제 및 길항제
JP2005538683A (ja) * 2001-12-14 2005-12-22 ターガセプト,インコーポレイテッド 中枢神経系疾患の治療のための方法及び組成物
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
AU2012203831B2 (en) * 2006-11-06 2013-12-19 Abbvie Bahamas Ltd Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
EP2497771A1 (en) * 2007-03-23 2012-09-12 Abbott Laboratories 4 -substituted azaadamantane derivatives and methods of use thereof
EP2619205B1 (en) 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrate of an azaadamantane derivative
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03135978A (ja) * 1989-08-08 1991-06-10 Merck Sharp & Dohme Ltd 置換ピリジン、その製法、処方並びに痴呆症における使用法
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
EP0492903A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
WO1995003306A1 (en) * 1993-07-22 1995-02-02 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
AU5383196A (en) * 1995-05-17 1996-11-29 R.J. Reynolds Tobacco Company Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
US5684159A (en) * 1995-05-30 1997-11-04 Rhone-Poulenc Rorer S.A. L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds

Similar Documents

Publication Publication Date Title
AU679761B2 (en) 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands
DK1023308T3 (da) Inhibitorer af nukleosidmetabolisme
CA2282585A1 (en) Pyrazine compounds
CA2275425A1 (en) Aminoindan derivatives
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
DE69133277D1 (de) Chelat-zubereitungen, die oximverbindungen enthalten
EP2266981A3 (en) Benzothiazole compounds useful as kinase inhibitors
CA2192824A1 (en) Pyridone-carboxylic acid derivatives, processes for the preparation thereof and anti-tumor agents containing the pyridone-carboxylic acid derivatives
CA2037923A1 (en) Oxindole derivative
EP0351112A3 (en) Photochromic compound, process for production thereof, use thereof and composition containing said photochromic compound
GR79780B (cg-RX-API-DMAC7.html)
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
CA2053640A1 (en) Quinoline derivatives
CA2503451A1 (en) Heterocyclic compounds and antitumor agent comprising the same as effective component
WO2001014330A3 (en) Phenylpiperazines as serotonin reuptake inhibitors
NZ505220A (en) Arylpiperazines having activity at the serotonin 1A receptor, processes for their preparation and intermediates
CA2088742A1 (en) Benzimidazole and imidazopyridine derivatives and their application
TW427979B (en) A condensed piperidine compound
EP0204309A3 (en) Substituted n-benzyl-4(benzhydryl) piperidines
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
AU676348B2 (en) New 2(1H)-quinolone compounds, process for their preparationand the pharmaceutical compositions which contain them
DK0951284T3 (da) Phenylethylminderivater
DE69219124D1 (de) Fungizide verbindungen
ES2183568T3 (es) Compuestos heterociclicos sustituidos con cinco miembros, composiciones fungicidas que los contienen y procedimientos de fabricacion de los mismos.
NZ508852A (en) 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use in treating CNS and circulation disorders